{
  "Cancer Histology Subtype (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3992, 
        3998
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4061, 
        4067
      ]
    }
  ], 
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3999, 
        4008
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4068, 
        4077
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3600, 
        3623
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3625, 
        3641
      ]
    }
  ], 
  "Comments Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6375, 
        6395
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6397, 
        6405
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3665, 
        3692
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3694, 
        3704
      ]
    }
  ], 
  "Laterality (Ov)": [
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        3643, 
        3648
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3707, 
        3712
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3928, 
        3933
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4270, 
        4275
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6244, 
        6249
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6289, 
        6294
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6344, 
        6349
      ]
    }
  ], 
  "Lymphatic System Location (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3713, 
        3741
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4276, 
        4304
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6250, 
        6277
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6350, 
        6369
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1239, 
        1268
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1270, 
        1287
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6188, 
        6214
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6216, 
        6234
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3983, 
        3991
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4078, 
        4085
      ]
    }
  ], 
  "Neoplasm Grade Value (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Ben,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4016, 
        4017
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        3649, 
        3655
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3934, 
        3940
      ]
    }, 
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        4787, 
        4794
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6295, 
        6301
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        1289, 
        1291
      ]
    }, 
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        1689, 
        1691
      ]
    }, 
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        3027, 
        3029
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3704, 
        3706
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3925, 
        3927
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4267, 
        4269
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6236, 
        6243
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6281, 
        6288
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6336, 
        6343
      ]
    }
  ], 
  "__text": "MSH|^~\\&|LABCORP-CORP|LABCORP^34D0655059^CLIA|Cancer Registry|State|201706010938|State006|ORU^R01|2017060107093839521000|P|2.3.1\nPID|1||^^^^SS^~11111111^^^^PI^|ALTERNATE ID|TEST^PATIENT^A||19500601|M||2054-5^Black or African American^CDC^^^|1234 Test Road^^ALBANY^NY^12201||^^^^^222^1234567|||||||\nORC|RE||111A1111111||||||||||||||||||Ordering Facility Name^^L|2222 W. Test Road^^Test^TX^77025|^^^^^111^1234567||\nOBR|1||111A1111111|^^^111111^Pathology Report^L|||201705301335|||||||20090115||Ordering Provider Name||||||20170530|||F|||||||\n\n\n\n\n\n\n\n\nSpecial s risks (95% CI) of distant recurrence were 40% (25%, 54%) for tam alone and 12% (6%, 18%) for tam + CMF/MF.1 Prediction of Chemotherapy Benefit after 5 Years of Tam, Based on the Recurrence Score Result (from NSABP B-20) Tam Alone:   Intermediate risk Tam + Chemo:   Intermediate risk Quantitative Single Gene Report ER Score =   10.3 Positive PR Score =   8.6 Positive HER2 Score =   8.2 Negative Laboratory Director:  Patrick Joseph, MD A complete copy of the report is on file. Professional services performed by Genomic Health, Inc. 301 Penobscot Drive, Redwood City, CA 94063. Technical services performed by Genomic Health, Inc. 301 Penobscot Drive, Redwood City, CA 94063.\n\n\nPath report.gross observation\n\nGross description: A. Received in formalin, labeled \"Bridges-right axillary sentinel lymph node #1\" is an irregular portion of yellow-tan fibrofatty tissue. The tissue is palpated to reveal 3 possible lymph nodes measuring up to 1.4 cm in greatest dimension. The 2 smaller apparent lymph nodes are submitted entirely in cassette A1 and the second lymph node is serially sectioned and submitted entirely in cassette A2. B. Received fresh for gross consult, labeled \"Bridges-right breast wire localized partial mastectomy, short stitch superior, long stitch lateral, Telfa deep\" is an irregular portion of yellow-tan fibrofatty tissue consistent with a wire localized, oriented breast excisional biopsy (34 g, 5.8 cm from medial to lateral, 5.0 cm from superior to inferior, and 3.2 cm from anterior to posterior). There are sutures denoting the superior and lateral aspects and Telfa denoting the deep aspect. The specimen margins are inked as follows: superior-red, inferior-black, medial-orange, lateral-yellow, anterior-blue, and posterior-green. The specimen is sectioned to reveal a firm, ill-defined white-tan mass measuring approximately 1.8 x 1.4 x 0.9 cm. This mass is located approximately: 0.2 cm from anterior, 1.3 cm from posterior, 1.5 cm from superior, 1.2 cm from inferior, 1.8 cm from medial, and 2.5 cm from lateral. The remainder of the cut surface is yellow-tan, fibrofatty and grossly unremarkable. Representative sections are submitted as follows: B1-mass to anterior B2-B4-full length transverse section, trisected B5-additional sections of mass to anterior B6-mass to posterior B7-mass to posterior and superior Time surgically removed: 1350 on 7/19/17, time placed in formalin: 1405 on 7/19/17, time of fixation: 31 hours 50 minutes C. Received in formalin, labeled \"Bridges-right axillary sentinel lymph node #2\" is an irregular portion of yellow-tan fibrofatty tissue. The tissue is palpated to reveal one lymph node measuring 1.2 cm in greatest dimension. This lymph node is bisected and submitted entirely in cassette C1. (JDM; 7/20/2017) PQRS Code: 3260F\n\n\nPayment procedure\n\nCPT                            .88307 88342 88307 88307 88342 88341 88329 88361 88363\n\n\nPATHOLOGIST NAME\n\nElectronically signed: Pathologist name, Pathologist\n\n\nDiagnosis ICD code\n\nPathologist provided ICD-10:C50.911 I89.8\n\n\nPath report.relevant Hx\n\nClinical history: Right breast cancer\n\n\nPath report.final diagnosis\n\nDiagnosis:A. Right axillary sentinel lymph node #1, biopsy:     - Lymph nodes (3) with reactive sinus histocytosis - no isolated tumor cells or metastatic carcinoma identified       (pan cytokeratin immunohistochemistry negative). B. Right breast, wire localized partial mastectomy:     - Invasive ductal carcinoma, Grade 3 (1.3 cm) with extensive intermediate grade ductal carcinoma in situ       (DCIS) with invasive tumor extending to within 1.5 mm of anterior margin and DCIS extending to within 0.14 mm       of closest posterior margin and 1.0 mm of anterior margin. C. Right axillary sentinel lymph node #2, biopsy:     - Lymph node (1) with reactive lymphohistiocytosis - no isolated tumor cells or metastatic carcinoma identified       (pan cytokeratin immunohistochemistry negative). SYNOPTIC REPORT Specimen:                  Excision with image guided localization Lymph Node Sampling:          Sentinel lymph nodes Specimen Laterality:             Right Tumor Site:                  Upper outer quadrant Tumor Size:                  1.3 cm Histologic Type:               Invasive mammary carcinoma of no special type (ductal, not otherwise specified) Histologic Grade   (Nottingham Histologic Score):   Tubular Differentiation - Score 3                       Nuclear Pleomorphism - Score 3                       Mitotic Rate - Score 2                       Overall Grade - Grade 3 Ductal Carcinoma in situ (DCIS):     DCIS is present - positive for extensive intraductal component (EIC)                       Size (Extent) of DCIS: Estimated size - 3 cm                       Architectural Pattern: Solid                       Nuclear Grade: Grade 2 (intermediate)                       Necrosis: Not identified Margins:                  Margins uninvolved by invasive carcinoma                       Distance from closest margin: 1.5 mm (anterior)                       Distance from anterior margin: 1.1 cm                       Margins uninvolved by DCIS                       Distance from closest margin: 0.14 mm (posterior)                       Distance from anterior margin: 1.0 mm                       Distance from medial margin: 1.5 mm Lymph Nodes:               Total number of lymph nodes examined (sentinel and nonsentinel): 4                       Number of sentinel lymph nodes examined: 4 Lymph-Vascular Invasion:        Not identified Pathologic Staging:             pT1c (sn) pN0 (i-) Additional Pathologic Findings:     Prior biopsy site fibrocystic changes\n\n\nPath report.site of origin\n\nMaterial submitted: Part: A Right axillary sentine lymph node #1 Part: B Right breast wire localized partial mastectomy Part: C Right axillary lymph node #2\n\n\nPath report.comments\n\nComment:Biomarker studies are pending on block B3. (FLP:pit; 7/22/2017)\n\n\n"
}